The maker of Invisalign clear aligners benefited from a near-monopoly in the invisible braces market and rapid expansion into more complex dental cases. : Increased by 103% .
Major breakthroughs in cystic fibrosis treatments powered consistent sales growth and investor optimism. : Gained 95% .
In 2017, the stock market experienced a significant bull run, with the delivering a total return of approximately 21.8% . Growth sectors—specifically technology, healthcare, and homebuilders —led the charge, while traditional "safe havens" like energy and commodities largely underperformed. Top Performing S&P 500 Stocks of 2017
This utility stock staged a massive comeback after strategic shifts and activist investor pressure led to asset sales and cost-cutting measures. : Surged 131% .
The maker of Invisalign clear aligners benefited from a near-monopoly in the invisible braces market and rapid expansion into more complex dental cases. : Increased by 103% .
Major breakthroughs in cystic fibrosis treatments powered consistent sales growth and investor optimism. : Gained 95% . good stocks to buy right now 2017
In 2017, the stock market experienced a significant bull run, with the delivering a total return of approximately 21.8% . Growth sectors—specifically technology, healthcare, and homebuilders —led the charge, while traditional "safe havens" like energy and commodities largely underperformed. Top Performing S&P 500 Stocks of 2017 The maker of Invisalign clear aligners benefited from
This utility stock staged a massive comeback after strategic shifts and activist investor pressure led to asset sales and cost-cutting measures. : Surged 131% . and homebuilders —led the charge